Page 3 – Sinophare Bio-technology Co., Ltd

Ampicillin Capsules 500mg | GMP Antibiotic Supplier

Ampicillin Capsules 500mg are oral broad-spectrum penicillin antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections, and other bacterial conditions.

Each capsule contains Ampicillin 500mg as the active pharmaceutical ingredient. The product is manufactured under strict GMP standards and complies with BP, USP requirements.

Key Features:

Broad-spectrum antibacterial activity
Stable quality and good dissolution
GMP certified production
Complete registration documents available
Wholesale and bulk supply supported

Storage: Store in a cool, dry place, protected from light and moisture.

Ampicillin Capsules 500mg | GMP Antibiotic Supplier Read More »

Artemether Injection | GMP Antimalarial Medicine Supplier

admin

Artemether Injection is a fast-acting artemisinin derivative indicated for the treatment of acute uncomplicated and severe falciparum malaria, including multidrug-resistant strains.
It exerts a potent antimalarial effect by destroying the intraerythrocytic forms of Plasmodium falciparum, with rapid onset and high clinical efficacy.
Manufactured under strict GMP conditions and compliant with BP, USP, and WHO guidelines.
Key Features:
Potent and rapid antimalarial action
Effective against drug-resistant malaria
Suitable for severe and complicated cases
Stable quality and consistent potency
GMP certified production
Complete registration documents available
Wholesale and bulk supply supported
Storage:
Store in a cool, dry place, protected from light and freezing.

Artemether Injection | GMP Antimalarial Medicine Supplier Read More »

Artemether Suspension Oral Powder 180mg | Antimalarial Oral Powder

admin

Specification
Each sachet contains:
Artemether 180 mg
Description
Artemether is a semi‑synthetic artemisinin derivative. It effectively kills the asexual erythrocytic stages of malaria parasites, rapidly reduces parasite density and relieves malarial fever symptoms. This oral powder is for suspension preparation, convenient for oral administration, suitable for adult and pediatric malaria treatment.
Indications
Treatment of uncomplicated falciparum malaria
Infection of vivax malaria and other plasmodium species
First-line oral monotherapy or combined antimalarial regimen
Storage
Store in cool dry place, tightly sealed, protected from light.
Reconstituted suspension should be used within the specified time.
Keep away from children.
Warning
For oral use only.
Contraindicated in patients with hypersensitivity to artemether or artemisinin components.
Use cautiously in liver and renal dysfunction.
Common side effects: mild dizziness, gastrointestinal discomfort, headache.
Not recommended for early pregnancy unless clinically necessary.
Complete the full treatment course to avoid drug resistance and recurrence.

Artemether Suspension Oral Powder 180mg | Antimalarial Oral Powder Read More »

Artemether-Lumefantrine Oral Suspension 180mg/1080mg, 60mL

admin

Specification
Total volume: 60 mL
Combined strength:
Artemether：180 mg
Lumefantrine：1080 mg
Description
Artemether-Lumefantrine is a standardized artemisinin combination therapy (ACT).
Artemether rapidly eliminates blood-stage malaria parasites and relieves acute symptoms; Lumefantrine provides long-lasting antimalarial action to clear residual parasites and prevent recurrence. The oral suspension is easy to administer, suitable for pediatric and administer, suitable for pediatric and vulnerable patients.
Indications
Treatment of uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax.
Recommended first-line combination antimalarial medicine for endemic regions.
Storage
Store tightly sealed in a cool, dry place, protected from direct sunlight.
Shake well before use.
Keep out of reach of children.
Warning
For oral use only.
Contraindicated in patients with hypersensitivity to artemether, lumefantrine or excipients.
Not for severe malaria; reserve injectable antimalarials for critical cases.
Common adverse reactions: mild headache, dizziness, gastrointestinal discomfort.
Avoid concurrent use with QT-prolonging drugs.
Complete the full treatment course to prevent drug resistance and relapse.
Use with medical supervision in pregnancy, lactation and hepatic impairment.

Artemether-Lumefantrine Oral Suspension 180mg/1080mg, 60mL Read More »

Artemether‑Lumefantrine Tablets | First‑Line ACT Antimalarial

admin

Artemether‑Lumefantrine Tablets are a fixed‑dose artemisinin‑based combination antimalarial.
Artemether: A fast‑acting artemisinin derivative that rapidly reduces parasite density and relieves symptoms.
Lumefantrine: A long‑acting blood schizonticide that eliminates remaining parasites and prevents treatment failure and recurrence.
The combination provides strong synergistic activity, high cure rates, and helps prevent the development of drug resistance.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including multidrug‑resistant strains) and Plasmodium vivax in adults and children.
Key Features
Rapid parasite clearance and quick fever resolution
High efficacy and low recurrence rate
Well‑tolerated and widely used globally
Standard 3‑day oral treatment course
Available in pediatric and adult strengths
Manufactured under strict GMP standards
Complies with WHO, USP, EP pharmacopoeial requirements
Full dossiers available for international registration
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription only medicine.
Contraindicated in patients with hypersensitivity to artemether, lumefantrine, or excipients.
May cause dizziness, headache, sleep disturbances, or gastrointestinal symptoms.
Use with caution in patients with cardiac disorders, hepatic or renal impairment.
Not suitable for severe malaria; parenteral antimalarials are required.
Administer under medical supervision.

Artemether‑Lumefantrine Tablets | First‑Line ACT Antimalarial Read More »

Artesunate / Mefloquine Tablets | Fixed‑Dose ACT Antimalarial

admin

Artesunate / Mefloquine Tablets are a fixed‑dose artemisinin‑based combination therapy (ACT) for the treatment of acute uncomplicated malaria.
Artesunate: Fast‑acting artemisinin derivative that rapidly reduces parasite load and relieves fever and clinical symptoms.
Mefloquine: Long‑acting blood schizonticide that eliminates remaining parasites and prevents recrudescence.
This combination provides potent synergistic activity, high cure rates, and helps delay the emergence of drug‑resistant malaria parasites.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including multidrug‑resistant strains) and Plasmodium vivax in adults and children.
Key Features
Rapid parasite clearance and early symptom relief
High efficacy against drug‑resistant falciparum malaria
Convenient 3‑day oral treatment course
Good compliance and well‑established safety profile
Suitable for use in endemic areas and travelers
Manufactured under strict GMP conditions
Complies with WHO, USP, EP pharmacopoeial standards
Full registration dossiers available for global market registration
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription‑only medicine.
Contraindicated in patients with hypersensitivity to artesunate, mefloquine, or related compounds.
Use with caution in patients with epilepsy, psychiatric disorders, cardiac conduction abnormalities, or hepatic/renal impairment.
Not intended for severe malaria; parenteral treatment is required.
Should be administered under medical supervision.

Artesunate / Mefloquine Tablets | Fixed‑Dose ACT Antimalarial Read More »

Artesunate and Amodiaquine Tablets | Fixed-Dose ACT Antimalarial

admin

Artesunate and Amodiaquine Tablets are a fixed‑dose artemisinin‑based combination therapy (ACT) widely recommended for the treatment of acute uncomplicated malaria.
Artesunate: A fast‑acting artemisinin derivative that rapidly reduces parasite load and relieves fever and clinical symptoms.
Amodiaquine: A long‑acting 4‑aminoquinoline that eliminates residual parasites and prevents recurrence.
The two components act synergistically to achieve high cure rates and delay the development of drug resistance.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including chloroquine‑resistant strains) and Plasmodium vivax in adults and children.
Key Features
Rapid parasite clearance and quick symptom relief
High efficacy and low recurrence rate
Well‑tolerated safety profile
Convenient oral administration, usually a 3‑day treatment course
Suitable for use in malaria‑endemic regions
Manufactured under strict GMP standards
Complies with WHO, USP, EP and international pharmacopoeial standards
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription‑only medicine.
Contraindicated in patients with hypersensitivity to artesunate, amodiaquine, or other quinoline derivatives.
Use with caution in patients with hepatic or renal impairment, hematological disorders, or G6PD deficiency.
Not suitable for severe malaria; parenteral antimalarials are required.
Administer under medical supervision.

Artesunate and Amodiaquine Tablets | Fixed-Dose ACT Antimalarial Read More »

Artesunate Injection 80mg | Antimalarial Injection

Artesunate Injection 60mg | Antimalarial Injection

admin

Each vial contains:
Artesunate …… 60 mg
Description
Artesunate is a potent semisynthetic artemisinin derivative that rapidly kills asexual blood stages of Plasmodium falciparum. It acts quickly, penetrates the blood–brain barrier, and is the first‑line treatment for severe malaria.
Indications
Severe falciparum malaria
Cerebral malaria
Multidrug‑resistant malaria
Malaria in pregnant women and children when clinically indicated
Storage
Store in a cool, dry place, protected from light.
Do not freeze.
Keep out of reach of children.
Warning
Prescription drug for intravenous / intramuscular use only.
Contraindicated in patients with hypersensitivity to artesunate or any artemisinin derivative.
Use with caution in patients with hepatic or renal impairment.
Monitor blood count, liver function and parasitemia during treatment.
May cause mild gastrointestinal symptoms, dizziness, or neutropenia.
Must be administered under medical supervision.

Artesunate Injection 60mg | Antimalarial Injection Read More »

Artesunate Suppositories | GMP Antimalarial Suppository for Severe Malaria

admin

Artesunate Suppositories are artemisinin derivative antimalarial suppositories for rectal administration, used for the treatment of acute and severe falciparum malaria, including multidrug-resistant strains.
They are particularly suitable for patients with convulsions, coma, severe vomiting, or who cannot receive oral or injectable treatment. The drug is rapidly absorbed through the rectal mucosa to quickly control parasitemia and reduce malaria progression.
Key Features:
Potent and rapid antimalarial effect
Effective against drug-resistant Plasmodium falciparum
Rectal administration, suitable for comatose and vomiting patients
Stable formulation, easy to store and use in field conditions
Good safety profile at therapeutic doses
Produced under strict GMP standards
Complete registration dossiers available for export
Storage
Store in a cool, dry place, protected from light and high temperature. Do not freeze.

Artesunate Suppositories | GMP Antimalarial Suppository for Severe Malaria Read More »

Artesunate Suspension 160mg | Oral Antimalarial Suspension

admin

Specification
Per bottle/sachet:
Artesunate 160 mg
Description
Artesunate is a fast-acting semi-synthetic artemisinin analog. It eliminates the asexual blood-stage malaria parasites, rapidly reduces fever and parasite load. Oral suspension formulation features quick absorption, mild irritation, suitable for oral administration in pediatric and adult patients.
Indications
Treatment of uncomplicated falciparum malaria
Therapy for Plasmodium vivax and other malaria infections
Routine antimalarial first-line oral treatment
Storage
Seal tightly, store in a cool and dry place, protect from light.
Avoid freezing.
Keep out of reach of children.
Warning
For oral use only.
Contraindicated in patients with hypersensitivity to artesunate or artemisinin derivatives.
Use with caution in hepatic or renal impairment.
Adverse reactions: mild nausea, dizziness, abdominal discomfort, transient weakness.
Complete the full treatment course to prevent malaria recurrence and drug resistance.
Caution in first trimester pregnancy, use only if prescribed by a physician.

Artesunate Suspension 160mg | Oral Antimalarial Suspension Read More »